JPWO2021168298A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021168298A5 JPWO2021168298A5 JP2022549811A JP2022549811A JPWO2021168298A5 JP WO2021168298 A5 JPWO2021168298 A5 JP WO2021168298A5 JP 2022549811 A JP2022549811 A JP 2022549811A JP 2022549811 A JP2022549811 A JP 2022549811A JP WO2021168298 A5 JPWO2021168298 A5 JP WO2021168298A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- intracellular signaling
- domain
- derived
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062979310P | 2020-02-20 | 2020-02-20 | |
| US62/979,310 | 2020-02-20 | ||
| US202063127843P | 2020-12-18 | 2020-12-18 | |
| US63/127,843 | 2020-12-18 | ||
| PCT/US2021/018847 WO2021168298A1 (en) | 2020-02-20 | 2021-02-19 | Inhibitory chimeric receptor architectures |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515471A JP2023515471A (ja) | 2023-04-13 |
| JP2023515471A5 JP2023515471A5 (https=) | 2024-02-29 |
| JPWO2021168298A5 true JPWO2021168298A5 (https=) | 2024-02-29 |
Family
ID=77392276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549811A Pending JP2023515471A (ja) | 2020-02-20 | 2021-02-19 | 抑制性キメラ受容体構造物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230272037A1 (https=) |
| EP (1) | EP4107174A4 (https=) |
| JP (1) | JP2023515471A (https=) |
| CN (1) | CN115298209A (https=) |
| TW (1) | TW202146436A (https=) |
| WO (1) | WO2021168298A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230109138A (ko) * | 2020-10-16 | 2023-07-19 | 센티 바이오사이언시스, 인코포레이티드 | 키메라 수용체 및 이의 사용 방법 |
| KR20250006910A (ko) * | 2022-04-20 | 2025-01-13 | 센티 바이오사이언시스, 인코포레이티드 | 항원 결합 도메인 및 이의 사용 방법 |
| CA3261358A1 (en) * | 2022-07-26 | 2024-02-01 | Senti Biosciences, Inc. | CHIMERIC RECEPTOR INHIBITOR ARCHITECTURES |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160296562A1 (en) * | 2013-11-21 | 2016-10-13 | Ucl Business Plc | Cell |
| US11072644B2 (en) * | 2014-11-12 | 2021-07-27 | Allogene Therapeutics, Inc. | Inhibitory chimeric antigen receptors |
| CA2978186A1 (en) * | 2015-03-05 | 2016-09-09 | Fred Hutchinson Cancer Research Center | Immunomodulatory fusion proteins and uses thereof |
| EP3380602A4 (en) * | 2015-11-23 | 2019-09-25 | Trustees of Boston University | METHOD AND COMPOSITIONS RELATED TO CHIMERIC ANTIGEN RECEPTORS |
| KR20200071740A (ko) * | 2017-09-28 | 2020-06-19 | 임팩트-바이오 리미티드. | 저해성 키메라 항원 수용체 (icar)를 제조하기 위한 보편적 플랫폼 |
| US20200316120A1 (en) * | 2018-09-28 | 2020-10-08 | Immpact-Bio Ltd. | METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (aCAR)/INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR) PAIRS FOR USE IN CANCER THERAPIES |
| EP3962527A4 (en) * | 2019-04-30 | 2023-11-01 | Senti Biosciences, Inc. | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF |
| JP2022546315A (ja) * | 2019-08-20 | 2022-11-04 | センティ バイオサイエンシズ インコーポレイテッド | キメラ抑制性受容体 |
-
2021
- 2021-02-19 CN CN202180021605.7A patent/CN115298209A/zh active Pending
- 2021-02-19 JP JP2022549811A patent/JP2023515471A/ja active Pending
- 2021-02-19 EP EP21756389.9A patent/EP4107174A4/en active Pending
- 2021-02-19 WO PCT/US2021/018847 patent/WO2021168298A1/en not_active Ceased
- 2021-02-19 TW TW110105858A patent/TW202146436A/zh unknown
-
2022
- 2022-08-18 US US17/820,804 patent/US20230272037A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019525771A5 (https=) | ||
| JP2024023228A5 (https=) | ||
| CN112912401B (zh) | 抗-l1细胞粘附分子抗体或其抗原结合片段及包含其的嵌合抗原受体 | |
| JP2025142045A5 (https=) | ||
| IL277398B2 (en) | Pd-l1 binding affimers, and uses related thereto | |
| JP2017524367A5 (https=) | ||
| TW202535924A (zh) | 抗ｄｌｌ３嵌合抗原受體及其用途 | |
| JP2020511529A5 (https=) | ||
| TW201920653A (zh) | 調節細胞表達的生物活性之結合分子 | |
| JP2020517295A5 (https=) | ||
| JP2021513857A5 (https=) | ||
| JP2018535701A5 (https=) | ||
| JP2018508215A5 (https=) | ||
| RS53008B2 (sr) | Interspecijski specifičan cd3-epsilon vezujući domen | |
| JP2021526844A5 (https=) | ||
| JP2021520820A5 (https=) | ||
| CN115916833A (zh) | 靶向b7h3的抗原结合多肽及其应用 | |
| US20220133792A1 (en) | Signaling platforms for chimeric antigen receptor t cells | |
| US20230321239A1 (en) | Chimeric antigen receptor t cells for treating autoimmunity | |
| CN120641113A (zh) | 靶向cd20和bcma的双特异性嵌合抗原受体 | |
| TW202430565A (zh) | 包含與il18組合之新穎cd19結合體之car-t構築體及其使用方法 | |
| JPWO2019245991A5 (https=) | ||
| JPWO2022081516A5 (https=) | ||
| US20240150456A1 (en) | Engineered immune cells and uses thereof | |
| JPWO2021168298A5 (https=) |